THROMBOTECH LTD has a total of 18 patent applications. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are MANCINI ALDO, MILKHAUS LAB INC and CONARIS RES INST AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 4 | |
#4 | United States | 3 | |
#5 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Enzymes | |
#6 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Higazi Abd Al-Roof | 15 |
#2 | Higazi Abd-Al-Roof | 2 |
#3 | Cines Douglas B | 1 |
Publication | Filing date | Title |
---|---|---|
WO2011086557A1 | Peptides for the treatment of respiratory diseases | |
WO2008018084A2 | Peptides derived from plasminogen activator inhibitor for preventing neuronal damage | |
US7271143B1 | Peptides for regulation of urokinase (uPA) and tissue type (tPA) plasminogen activator and method of optimizing therapeutic efficacy | |
CA2453309A1 | Peptide for regulation of tissue plasminogen activator | |
US6759042B2 | Use of cross-linked, covalently bound urokinase plasminogen activator (scuPA)-urokinase plasminogen activator receptor (suPAR) complex as a fibrinolytic agent | |
US6911316B1 | Medical uses of scuPA/suPAR complex |